BRIEF-FDA approves Genentech's cancer immunotherapy Tecentriq
October 18, 2016 at 17:21 PM EDT
* FDA approves Genentech's cancer immunotherapy Tecentriq (atezolizumab) for people with a specific type of metastatic lung cancer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.